Corregene Biotechnology

Business Services · United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Corregene Biotechnology

Beijing Corregene Biotechnology Co., Ltd. is dedicated to becoming a leading enterprise in the global TCR immunotherapy field, focusing on the development of TCR-T cell drugs and TCR protein drugs. Their innovative SMART-TCR affinity optimization platform significantly enhances the success rate and efficiency of TCR affinity optimization, addressing various technical challenges in TCR cloning and optimization. The company aims to develop therapies for tumors, chronic infections, and autoimmune diseases, targeting a trillion-dollar market. Their products are designed to provide effective treatments with improved safety and accessibility.Explore more
Corregene Biotechnology's Social MediaPopular SearchesCorregene Biotechnology Co LtdCorreGene BiotechnologySIC Code 87,873NAICS Code 54,541Show more

Corregene Biotechnology Org Chart

XX
United States flag for contact location.

Chief Executive Officer

PhoneEmail
DJ
United States flag for contact location.

Chief Technology Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Corregene Biotechnology your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Corregene Biotechnology

Compare insights from companies similar to Corregene Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Corregene Biotechnology

<$5M
11-50
Private
-
2016
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
<$5M
51-200
Public
$130M
2016
CB
Carsten BrunnPresident & CEO
<$5M
1-10
Private
-
2019
JL
Jeffrey LiterPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Corregene Biotechnology is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Corregene Biotechnology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Corregene Biotechnology.

Corregene Biotechnology Tech Stack

A closer look at the technologies used by Corregene Biotechnology

See more technologies

Top Business Services Companies

Frequently Asked Questions Regarding Corregene Biotechnology

What is Corregene Biotechnology's official website?
Corregene Biotechnology's official website is www.corregene.com
What is Corregene Biotechnology's Revenue?
Corregene Biotechnology's revenue is <$5 Million
What is Corregene Biotechnology's SIC code?
Corregene Biotechnology's SIC: 87,873
What is Corregene Biotechnology's NAICS code?
Corregene Biotechnology's NAICS: 54,541
How many employees does Corregene Biotechnology have?
Corregene Biotechnology has 11-50 employees
What industry does Corregene Biotechnology belong to?
Corregene Biotechnology is in the industry of: Business Services, Research & Development
What is Corregene Biotechnology competition?
Corregene Biotechnology top competitors include: Cartesian Therapeutics, Luminary Therapeutics, ALTuCELL, TCA Cellular Therapy
What technology does Corregene Biotechnology use?
Some of the popular technologies that Corregene Biotechnology uses are: Alibaba Cloud
Who is the CTO of Corregene Biotechnology?
Corregene Biotechnology's CTO is Dong Jiang
What does Corregene Biotechnology do?

Beijing Corregene Biotechnology Co., Ltd. is dedicated to becoming a leading enterprise in the global TCR immunotherapy field, focusing on the development of TCR-T cell drugs and TCR protein drugs. Their innovative SMART-TCR affinity optimization platform significantly enhances the success rate and efficiency of TCR affinity optimization, addressin... g various technical challenges in TCR cloning and optimization. The company aims to develop therapies for tumors, chronic infections, and autoimmune diseases, targeting a trillion-dollar market. Their products are designed to provide effective treatments with improved safety and accessibility.Read More

What are Corregene Biotechnology social media links?
Corregene Biotechnology Linkedin page
Is Corregene Biotechnology a public company?
Corregene Biotechnology is private company therefore does not currently have an official ticker symbol
See more information about Corregene Biotechnology

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.